BERLIN: Germany does not expect a coronavirus vaccine to be available before the first quarter of 2021, according to a copy of its national vaccine strategy seen by Reuters on Monday.The 15-page strategy paper from the health ministry sets out seven potential vaccines which are expected to complete testing this year or next and could be available in sufficient amounts to begin a nationwide vaccination campaign for priority groups.These include shots from AstraZeneca, BioNTech and its partner Pfizer, Moderna and Novovax, Johnson & Johnson, GlaxoSmithKline and CureVac."Assuming that a favourable risk-benefit ratio can be confirmed, first approvals are expected in Q1/2021 at the earliest," the paper says.Germany plans to set up centralised.